135 related articles for article (PubMed ID: 11438132)
1. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
Robinson DS; Campbell D; Barnes PJ
Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
Deykin A; Wechsler ME; Boushey HA; Chinchilli VM; Kunselman SJ; Craig TJ; DiMango E; Fahy JV; Kraft M; Leone F; Lazarus SC; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
Am J Respir Crit Care Med; 2007 Feb; 175(3):228-34. PubMed ID: 16973987
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled, crossover study in patients with mild and moderate asthma undergoing treatment with traditional Chinese acupuncture.
Pai HJ; Azevedo RS; Braga AL; Martins LC; Saraiva-Romanholo BM; Martins Mde A; Lin CA
Clinics (Sao Paulo); 2015 Oct; 70(10):663-9. PubMed ID: 26598077
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study of leukotriene modifier response in asthma.
Dahlin A; Litonjua A; Irvin CG; Peters SP; Lima JJ; Kubo M; Tamari M; Tantisira KG
Pharmacogenomics J; 2016 Apr; 16(2):151-7. PubMed ID: 26031901
[TBL] [Abstract][Full Text] [Related]
5. Prescribing of β-adrenoceptor antagonists in asthma: an observational study.
Morales DR; Guthrie B; Lipworth BJ; Donnan PT; Jackson C
Thorax; 2011 Jun; 66(6):502-7. PubMed ID: 21459857
[TBL] [Abstract][Full Text] [Related]
6. Asthma genetics and personalised medicine.
Meyers DA; Bleecker ER; Holloway JW; Holgate ST
Lancet Respir Med; 2014 May; 2(5):405-15. PubMed ID: 24794577
[TBL] [Abstract][Full Text] [Related]
7. Short-term effect of the addition of leukotriene receptor antagonists to the current therapy in severe asthmatics.
Tonelli M; Zingoni M; Bacci E; Dente FL; Di Franco A; Giannini D; Taccola M; Vagaggini B; Paggiaro PL
Pulm Pharmacol Ther; 2003; 16(4):237-40. PubMed ID: 12850127
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and Management of Difficult-to-Treat and Severe Asthma: An Expert Opinion From the Korean Academy of Asthma, Allergy and Clinical Immunology, the Working Group on Severe Asthma.
Kim BK; Park SY; Ban GY; Kim MA; Lee JH; An J; Shim JS; Lee Y; Won HK; Lee HY; Sohn KH; Kang SY; Park SY; Lee H; Kim MH; Kwon JW; Yoon SY; Lee JH; Rhee CK; Moon JY; Lee T; Kim SR; Park JS; Kim SH; Park HW; Jeong JW; Kim SH; Koh YI; Oh YM; Jang AS; Yoo KH; Cho YS;
Allergy Asthma Immunol Res; 2020 Nov; 12(6):910-933. PubMed ID: 32935486
[TBL] [Abstract][Full Text] [Related]
9. Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies.
Jenkins C
Ther Clin Risk Manag; 2019; 15():423-435. PubMed ID: 30936705
[TBL] [Abstract][Full Text] [Related]
10. Repeated exacerbation of asthma: An intrinsic phenotype of uncontrolled asthma.
Jain N; Satish K; Abhyankar N; Velayudhan N; Gurunathan J
Lung India; 2019; 36(2):131-138. PubMed ID: 30829247
[TBL] [Abstract][Full Text] [Related]
11. Innovative Therapies for Severe Asthma.
Christensen MA; Ott M
Fed Pract; 2017 Dec; 34(12):25-31. PubMed ID: 30766246
[TBL] [Abstract][Full Text] [Related]
12. Tiotropium for the Treatment of Asthma: Patient Selection and Perspectives.
Chari VM; McIvor RA
Can Respir J; 2018; 2018():3464960. PubMed ID: 29670674
[TBL] [Abstract][Full Text] [Related]
13. Step 4: stick or twist? A review of asthma therapy.
Slater MG; Pavord ID; Shaw DE
BMJ Open Respir Res; 2016; 3(1):e000143. PubMed ID: 27651907
[TBL] [Abstract][Full Text] [Related]
14. Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma - a pilot study.
Kononowa N; Michel S; Miedinger D; Pichler CE; Chhajed PN; Helbling A; Leuppi JD
J Drug Assess; 2013; 2(1):49-57. PubMed ID: 27536437
[TBL] [Abstract][Full Text] [Related]
15. Korean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014.
Kim DK; Park YB; Oh YM; Jung KS; Yoo JH; Yoo KH; Kim KH;
Tuberc Respir Dis (Seoul); 2016 Jul; 79(3):111-20. PubMed ID: 27433170
[TBL] [Abstract][Full Text] [Related]
16. Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran.
Ansarin K; Attaran D; Jamaati H; Masjedi MR; Abtahi H; Alavi A; Aliyali M; Asnaashari AM; Farid-Hosseini R; Ghayumi SM; Ghobadi H; Ghotb A; Halvani A; Nemati A; Rahimi Rad MH; Rahimian M; Sami R; Sohrabpour H; Tavana S; Torabi-Nami M; Vahedi P
Tanaffos; 2015; 14(2):73-94. PubMed ID: 26528362
[TBL] [Abstract][Full Text] [Related]
17. Side Effects of Leukotriene Receptor Antagonists in Asthmatic Children.
Erdem SB; Nacaroglu HT; Unsal Karkiner CS; Gunay I; Can D
Iran J Pediatr; 2015 Oct; 25(5):e3313. PubMed ID: 26495098
[TBL] [Abstract][Full Text] [Related]
18. Bronchial thermoplasty in asthma: current perspectives.
Laxmanan B; Hogarth DK
J Asthma Allergy; 2015; 8():39-49. PubMed ID: 26028976
[TBL] [Abstract][Full Text] [Related]
19. Severe asthma in children.
Guilbert TW; Bacharier LB; Fitzpatrick AM
J Allergy Clin Immunol Pract; 2014; 2(5):489-500. PubMed ID: 25213041
[TBL] [Abstract][Full Text] [Related]
20. Severe asthma: an expanding and mounting clinical challenge.
Bell MC; Busse WW
J Allergy Clin Immunol Pract; 2013 Mar; 1(2):110-21; quiz 122. PubMed ID: 24565450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
